mardi 2 juillet 2019

Onco Actu du 2 juillet 2019


1. BIOLOGIE



Hidden layer of gene control influences everything from cancer to memory [Science]











1.4 BIOLOGIE - TECHNOS



Walter Isaacson is writing a book about CRISPR. He’s got company [STAT]











3.7 PRÉVENTION - ALCOOL



Alcoholic beverages should carry cancer warnings, health groups say [CBS]











4.3 DÉP., DIAG. & PRONO. - INDUSTRIELS



Foundation Medicine Expands Indication for FoundationOne®CDx as a Companion Diagnostic for LYNPARZA® (Olaparib) [Foundation Medicine]











5. TRAITEMENTS



Tumour treating fields in glioblastoma: indication of a benefit [IQWIG]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



Researchers clock DNA's recovery time after chemotherapy [UNC]











Response to gene-targeted drugs depends on cancer type [Institute of Cancer Research]










5.12.5 IMMUNOTHÉRAPIES - PHARMA



Bayer backs cell therapy startup with $215M in funding [Biopharma Dive]











Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform [Bayer]











5.17 TRAITEMENTS - RADIOTHÉRAPIE



Shorter Courses of Proton Therapy Can Be Just as Effective as Full Courses in Treating Prostate Cancer [Penn Medicine]











Focusing on Proton Therapy [Cancer Today]










5.2 PHARMA



Puma Biotechnology Submits a Supplemental New Drug Application to U.S. FDA for Neratinib to Treat HER2-Positive Metastatic Breast Cancer [Puma











5.2.2 PHARMA - FUSIONS & ACQUISITIONS



Array pushed Pfizer for a higher price to get deal done [Biopharma Dive]











5.2.3 PHARMA - ÉCONOMIE



Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS [Fierce Pharma]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



EMA Recommends Extension of Indications for Ramucirumab [ESMO]











6. LUTTE CONTRE LES CANCERS



Newly diagnosed cancer patients should be prescribed fitness plans [The Telegraph]











6.1 OBSERVATION



Fertility treatment not associated with added long-term risk of ovarian cancer [Focus on Reproduction]










NIH study finds long-term increased risk of cancer death following common treatment for hyperthyroidism [NIH]










6.10 POLITIQUES



UK-led cancer and climate trials at risk as British researchers become liability [The Guardian]










6.6 PUBLICATIONS



Publication Rankings [In The Pipeline]











6.7 DMP, BIG DATA & APPLIS



MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles [Genome Web]











6.7.2 APPLIS



Cancer social network app Belong.Life raises $14 million in private funding [Reuters]